Gilbert Fuller Sells 1,057 Shares of USANA Health Sciences (NYSE:USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert Fuller sold 1,057 shares of the company’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $21.48, for a total transaction of $22,704.36. The transaction was disclosed in a filing with the SEC, which is available at this link.

USANA Health Sciences Stock Performance

NYSE:USNA traded down $0.70 during midday trading on Tuesday, reaching $20.55. 102,228 shares of the stock traded hands, compared to its average volume of 192,244. The company has a fifty day moving average of $26.57 and a 200 day moving average of $28.82. USANA Health Sciences, Inc. has a 12 month low of $18.69 and a 12 month high of $41.83. The stock has a market capitalization of $375.49 million, a P/E ratio of 23.35, a PEG ratio of 0.94 and a beta of 0.61.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings results on Thursday, October 9th. The company reported $0.56 EPS for the quarter. USANA Health Sciences had a net margin of 1.86% and a return on equity of 6.96%. The company had revenue of $200.22 million during the quarter. USANA Health Sciences has set its Q3 2025 guidance at -0.150–0.150 EPS. On average, analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on the stock. Wall Street Zen lowered shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Zacks Research lowered shares of USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Tuesday, October 21st. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of USANA Health Sciences in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $36.00.

Institutional Trading of USANA Health Sciences

Several institutional investors have recently bought and sold shares of USNA. PNC Financial Services Group Inc. grew its position in USANA Health Sciences by 339.6% during the 1st quarter. PNC Financial Services Group Inc. now owns 998 shares of the company’s stock valued at $27,000 after purchasing an additional 771 shares during the last quarter. Tower Research Capital LLC TRC grew its position in USANA Health Sciences by 382.5% during the 2nd quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock valued at $73,000 after purchasing an additional 1,901 shares during the last quarter. CWM LLC grew its position in USANA Health Sciences by 109.7% during the 2nd quarter. CWM LLC now owns 2,762 shares of the company’s stock valued at $84,000 after purchasing an additional 1,445 shares during the last quarter. AlphaQuest LLC grew its position in USANA Health Sciences by 300.9% during the 1st quarter. AlphaQuest LLC now owns 3,412 shares of the company’s stock valued at $92,000 after purchasing an additional 2,561 shares during the last quarter. Finally, Quantbot Technologies LP grew its position in USANA Health Sciences by 19.5% during the 2nd quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock valued at $121,000 after purchasing an additional 646 shares during the last quarter. 54.25% of the stock is owned by hedge funds and other institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.